--- title: "Sunfar's controlling shareholder, Sun Renjing, has cumulatively increased his holdings by 3.2402 million shares" type: "News" locale: "en" url: "https://longbridge.com/en/news/242220992.md" description: "According to the Zhitong Finance APP, Sunfar announced that its controlling shareholder, Sun Renjing, will cumulatively increase his holdings of the company's shares by 3.2402 million shares through centralized bidding from June 3, 2024, to May 28, 2025, accounting for 0.85% of the company's total share capital. This increase plan has been completed" datetime: "2025-05-28T13:07:03.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/242220992.md) - [en](https://longbridge.com/en/news/242220992.md) - [zh-HK](https://longbridge.com/zh-HK/news/242220992.md) generator: "portal-rs" --- # Sunfar's controlling shareholder, Sun Renjing, has cumulatively increased his holdings by 3.2402 million shares According to the Zhitong Finance APP, Sunfar (603938.SH) announced that its controlling shareholder, Sun Renjing, will cumulatively increase his holdings of the company's shares by 3.2402 million shares through centralized bidding from June 3, 2024, to May 28, 2025, accounting for 0.85% of the company's total share capital. This increase plan has been completed ### Related Stocks - [603938.CN](https://longbridge.com/en/quote/603938.CN.md) ## Related News & Research - [How did America survive its first debt crisis?](https://longbridge.com/en/news/298831312.md) - [Aignostics lance PathoSearch, un moteur de recherche visuel dédié aux cas pathologiques](https://longbridge.com/en/news/298827083.md) - [Havas, linked to Louis Hachette director Yannick Bolloré, purchases EUR 5.31 million of Louis Hachette Group shares](https://longbridge.com/en/news/298621675.md) - [Wall St Week Ahead-Investors brace for possible rate hike at uncertain Fed meeting](https://longbridge.com/en/news/298831878.md) - [FDA Approves Tablet Form of Zanubrutinib for All Approved Indications](https://longbridge.com/en/news/298434766.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**